A Study of LY3361237 in Participants With Psoriasis

Summary

The main purpose of this study is to learn more about the safety and tolerability of LY3361237 and any side effects that might be associated with it when given to participants with psoriasis. LY3361237 will be administered by injections just under the skin. The study will last up to 41 weeks and may include up to 15 visits to the study center.

Timeline

Start

2021-07-27

Primary completion

2022-11-29

Completion

2022-11-29

Drugs

Indications